We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Test for Cow's Milk Allergy Is Non-Invasive

By HospiMedica staff writers
Posted on 15 May 2007
A ready-to-use patch test has been developed for diagnosing cow's milk allergy. More...


A dry, disc-shaped cutaneous device system holds an active ingredient in powder form on an electrically charged plastic film that is delivered only when placed on the skin. Application of the disc creates an occlusive chamber between the disc and the skin, making the chamber's conditions humid enough to hydrate and release the active ingredient, and to open the skin's pores to better absorb the active ingredient.

Developed by DBV Technologies (Boulogne Billancourt, France) the device system, Viaskin, for the cutaneous administration of proteins and peptides is based on a new technology: Diallertest Milk. The company presented Viaskin and its applications at the BIO Business Forum on May 8, 2007, in Boston (MA, USA).

Diallertest Milk uses this technology to diagnose cow's milk protein allergy and is suitable for everyday medical practice. Practical, simple to use, and painless as it is completely non-invasive, and it can be applied directly by the parents to the child's back at home. It significantly improves the effectiveness in the diagnosis of cow's milk protein allergy. DBV is also developing Diallertest to diagnose dust mite, soy, and wheat allergies.

The milk allergy test will soon be available in the United States. DBV Technologies and Numico, a Dutch company specializing in the production and sale of nutritional foodstuffs, have announced a distribution agreement for Diallertest Milk that will extend its original network to include the entire world. Today, about 70,000 tests have already been prescribed. The test is available in Australia, France, the Middle East, and New Zealand.


Related Links:
DBV Technologies

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.